To further explore the role of TPX2 in advanced PDAC, we examined the tumour tissue of 139 patients from two independent study cohorts for its expression by immunohistochemistry and assessed its correlation with the patients ́ clinicopathological characteristics including outcome. The gene discussed is TPX2; the disease is neoplasm.